Anti-cancer
Imatinib Mesylate
Also known as: Imatinib, Imatinib Mesilate
CAS No.
220127-57-1
A tyrosine kinase inhibitor used in oral oncology formulations for chronic myeloid leukemia and gastrointestinal stromal tumors.
Imatinib Mesylate is a first-in-class tyrosine kinase inhibitor oncology API manufactured by NovaAcura Biotech under strict GMP quality systems. Full batch documentation and regulatory support are available for global oncology formulation partners.
Applications & Uses
A tyrosine kinase inhibitor used in oral oncology formulations for chronic myeloid leukemia and gastrointestinal stromal tumors.
Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.
Need This Molecule at Scale?
Get in touch for pricing, lead times and full regulatory documentation.
Get In Touch